Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board
Portfolio - People | Nov 22, 2024 | Digitalis Ventures LLC
Faeth Therapeutics, a clinical-stage biotechnology company focused on metabolic oncology, has appointed two high-profile experts to its board of directors: Dr. Stephen Hahn, former FDA Commissioner and oncology expert, and Dr. Jayson Dallas, former CEO of Aimmune Therapeutics and current CEO of Rivus Pharmaceuticals. These appointments will strengthen Faeth's leadership as the company advances its metabolic therapies that aim to improve cancer outcomes. Faeth utilizes an AI-driven platform called MetabOS to revolutionize cancer treatment through targeting metabolic processes. Dr. Hahn and Dr. Dallas bring extensive expertise in oncology, regulatory affairs, commercialization, and biotech operations to Faeth's strategic leadership, further aiming to transform treatment paradigms and unlock new drug development opportunities.
Sectors
- Biotechnology
- Healthcare
Geography
- United States – Faeth Therapeutics is based in Austin, Texas, and the newly appointed board members have had significant careers within the U.S. healthcare and biotechnology sectors.
Industry
- Biotechnology – Faeth Therapeutics operates within the biotechnology industry, focusing on oncology therapies developed through an AI-driven platform targeting cancer metabolism.
- Healthcare – The appointments of Dr. Stephen Hahn and Dr. Jayson Dallas are relevant to the healthcare industry due to their substantial backgrounds in medical oncology, regulatory affairs, and biotech leadership.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Faeth Therapeutics | Target company | Company | A clinical-stage biotechnology company focused on developing metabolic oncology therapies. |
| Dr. Stephen Hahn | Board member | Person | Former FDA Commissioner and radiation oncologist with extensive experience in oncology and regulatory leadership. |
| Dr. Jayson Dallas | Board member | Person | Accomplished biotech leader, former CEO of Aimmune Therapeutics, and current CEO of Rivus Pharmaceuticals. |
| Digitalis Ventures LLC | Private Equity Firm | Company | PE firm backing Faeth Therapeutics. |
| Rivus Pharmaceuticals | Company associated with Dr. Dallas | Company | Biopharmaceutical company led by Dr. Jayson Dallas. |